Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ㉥ 75 years: results of a real-world cohort including 456 patients
Author:
|
Gawaz, A.; Wolff, I.; Nanz, L.; Flatz, L.; Forschner, A.
|
Tübinger Autor(en):
|
|
Published in:
|
Cancer Immunology Immunotherapy
(2024), Bd.
73 (9),
Article 185
|
Verlagsangabe:
|
New York : Springer
|
Language:
|
English
|
Full text:
|
http://dx.doi.org/10.1007/s00262-024-03750-1
|
ISSN:
|
0340-7004
|
DDC Classifikation:
|
570 - Life sciences; biology 610 - Medicine and health
|
Dokumentart:
|
Article
|
Show full item record
|